| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |